Balanced Thc Cbd Type Iii

Type III cannabis represents a chemotype classification where THC and CBD concentrations exist in relatively balanced ratios, typically ranging from approximate parity to moderate variations between the two cannabinoids. This classification emerged from cannabinoid research and breeding documentation that identified plants producing meaningful levels of both major cannabinoids, distinguishing them from THC-dominant (Type I) or CBD-dominant (Type II) chemotypes. Type III genetics are less common in commercial cultivation but represent a distinct breeding category within cannabis genetics documentation. The balanced profile reflects specific allelic combinations in cannabinoid synthase genes that breeders have selectively worked with, particularly in European and research-oriented programs. Understanding Type III chemotypes contributes to the broader genetic framework used in cannabis taxo

Breeders targeting Type III chemotypes work with parent genetics known to express dual cannabinoid production, employing selective crossing strategies to stabilize balanced ratios across generations. Documentation of these genetics serves the breeding community in mapping cannabinoid inheritance patterns and developing stabilized lines for specific cannabinoid profiles.